Lunch Activity/Non-Certified Satellite Symposium - Takeda - Ticketed event. Limited seating.

Identifying appropriate patients for NINLARO® (ixazomib): an oral treatment option for patients with multiple myeloma

Toni Klatt-Ellis, APRN, MN, AOCN
Takeda Oncology